Endometriosis is a chronic incurable disorder of unknown etiology affecting a large proportion of women in reproductive age. In order to understand the pathogenesis and preclinical testing of drugs,animal models that recapitulate the key features of the disorder are highly desirous. Herein, we describe the ontogeny of the ectopic endometrial lesion in a mouse model where uterine tissue was ligated to the intestinal mesentery and the animals were followed up from day 5 to day 60 post-surgery. Out of 60 animals that underwent surgery, 58 developed endometriosis using this strategy. Most lesions were pale, fluid filled while red lesions were seen in ~10% of animals. Histologically, in most animals there was one large cystic gland with well differentiated epithelium, in 13% of animals there was mixed phenotype (well and poorly differentiated). There was extensive stromal compaction and increased number of macrophages in ectopic lesions. During the course of endometriosis, there was an increase in number of PCNA positive epithelial and stromal cells. The epithelial cells at all the time point were cytokeratin positive and the stroma was vimentin positive. However, at day 30 and 60, the stromal cells were also cytokeratin positive. The mRNA levels of estrogen receptors Esr1 and Gper1 were reduced while those of
Esr2 were elevated as compared to normal endometrium, the levels of progesterone receptor (Pgr) were found to be downregulated in ectopic lesions as compared to control. However, these differences were not statistically significant due to high biological variability. Low abundance of Cyp19a1 transcripts (aromatase gene) were only detected in the ectopic endometrium. Immunohistochemically, the expression of ERα and ERβ was significantly reduced only in stromal cells; the epithelial cell staining was maintained. GPER1 and PR immunoreactivity was significantly low in both epithelial and stromal cells. The immunostaining of all the steroid receptors was highly heterogeneous in the ectopic tissues with some areas of sections had stained intensely while others had negligible staining. We propose that temporal and spatial difference in the expression of steroid hormone receptors during the course of endometriosis development coupled with micro-heterogeneity may alter the effectiveness of steroid hormone analogues resulting in variable outcomes and often failure of therapy.
INTRODUCTUION
Endometriosis is a chronic benign gynecological disorder that results from growth of endometrial glands and stroma outside the uterine cavity. Globally~16. However, clinical observations demonstrate none to very moderate effect of these steroid hormone receptors modulators (SERMs) on endometriosis. Wholesome studies have shown very promising effects; others have shown no effects in improving symptoms of endometriosis (Ferrero et al. 2015) . At present, the reasons for such discrepant findings are unclear.
Estrogen and progesterone act in the target tissue via their receptors mainly the estrogen receptors (ERs) and progesterone receptors (PRs). Several investigators have assessed the expression of ER and PR in endometriotic lesions and the observations vary from study to study. Some studies have shown lower expression of estrogen and progesterone receptors in endometriotic tissue (Li et . Presently, it is not clear whether such contrasting observations are due to disparity in patient characteristics across the studies or there are inherent differences in the level of these receptors in different types of endometriosis. Furthermore, little is known about the changes that may occur in the receptor's expression profile during the growth of endometriotic lesions. Considering the importance of steroid hormone therapies in endometriosis, there is a growing need directed towards better understanding of the involvement of steroid hormone receptors in the course of endometriosis. For development of rational therapeutic strategies, it is essential to have a complete understanding of the disease. While the contributions from human studies are of high value, animal models for endometriosis are highly desirous as they allow us to carry out long term evaluations in controlled conditions. Several non-human primate and rodent models have been described for endometriosis ( Despite these applications, the surgical model of endometriosis in the mouse has not been well characterized. In most of the studies, the phenotypes of the ectopic endometrial lesions are studied at a single time point (generally at 30-45 days after induction of the lesions); limited studies have evaluated the evolution and the characteristics of the lesion in animals (Zhao et al. 2014, Eggermont et al.2005).Furthermore, despite being the strong targets for therapy, limited information exists on the spatial and temporal changes in the expression of steroid hormone receptors in the endometrioticlesions inthis model. In this study, we aimed to study theevolution ofectopic endometrial lesion in a surgically induced autotransplantation mouse model. In addition, we present the spatio-temporal changes in the expression of estrogen receptors (ERα, ERβ & GPER1) and progesterone receptors (PR) in the ectopic endometrium of the mouse model of induced endometriosis.
RESULS
In all, surgery was performed in 60animals, out of which ectopic lesions were observed in 58 (regressed in two animals) animals resulting in 96.5% success rate.
Anatomy of the ectopic lesions
Endometrial fragments were surgically implanted on intestinal mesentery and thelesionswereevaluated on day5, 10, 15, 30, 45 and 60 post-surgery (Fig.1A) . Macroscopically, ectopic lesionsonday 5, 10 & 15 post-surgery were small but appeared distinct on the intestinal mesentery. The lesions grew in size and by day 30, they appeared large and fluid filled. In most of the animals, lesions were pale and translucent, while in some animals, there werefew hemorrhagic sites within the lesions giving them a reddish appearance (Fig.1B) . On day 45 and day 60, the lesion size and appearance remained consistent like that of day 30. Two animals, were studied for120 dayspost-surgery and there were no major changes in its appearance (not shown) In all the animals, where a single fragment was sutured, one lesion was recovered. In animals, where two fragments were sutured, two lesions were recovered. There was no evidence of de novo lesion development in any of the animals. Adhesions were not detected in any of the animals on days 5-15 after induction of endometriosis. On day 30, in50% of animals, the lesions had adhesions around the tissue. On day 45 and day 60, all the animals developed dense adhesions attached to the intestine and the lesions werecompletely buried in them (Fig.1B) .At all the time points, the adhesions were always pale white with occasional hemorrhagic sites.
Histological features of the ectopic lesions
Histologically, theectopic endometrial tissue hadwell-developed glands and stroma at all time points. On day 5, the tissue showed glands and stroma that appeared identical to the control endometrium( Fig.2A) . Day 10 onwards, in all the animals, there was a singlecystic gland with large lumen that appeared fluid filled. This cystic gland enlarged in size over time. The epithelial lining sometimes flattened in some areas whereas it was columnar in other areas of the same gland. In tissues collected on day 30 and 45, the cystic glands showed irregular finger like projections similar to lamellae ( Fig.2A) . By day 60, the cystic glands showed multiple lamellae likeprojections. Epithelium layer appeared thickened and was multilayered in some areas of endometriotic tissue whereas the other glands were small and identical to the endometrium of control animals ( Fig.2A) . As compared to control endometrium, in all the ectopic lesions from day 15 onwards thestroma was compactand was hyperplastic. There was no evidence of fibrosis at any time point. In most animals,hemosiderin loaded macrophages were observed in the stroma of ectopic lesions from day10 and further ( Fig.2A) . No other signs of inflammation were evident in any of the lesions at any time point. Histologically, most of the lesions resembled well-differentiated type of endometriosis; a small subset of animals had mixed appearance with well-differentiated and poorly differentiated lesions; stromal type of histology was never observed in this model (Fig.2B ).
Vimentin and Cytokeratin expression in ectopic lesion
To assess cellular composition of these ectopic lesions, we performed immunohistochemistry for vimentin (stromal marker) and cytokeratin (epithelial marker) in ectopic lesions and in endometrium of control animals. Similar to controls, the stromal cells were strongly stained for vimentin and epithelial cells were stained positive for cytokeratin in the ectopic lesions (Fig.3A  & 3C) . Quantitatively, as compared to eutopic controls, the expression of vimentin in stroma was marginal but significantly reduced (P<0.05) on day 15. However, on day 30 and 60,expression of vimentin was similar to controls (Fig.3B) . As compared to controls, the expression of cytokeratin was significantly (P<0.05) increased in epithelial cells at day 15 and 30. However, by day 60, expression of cytokeratin was similar to endometrium of controls (Fig.3D) . At some time points, the stroma appeared to be weak but specifically cytokeratin positive (Fig.3C ).
Epithelial and stromal cell proliferation is increased in the ectopic lesions
To understand the extent of cell proliferation in the ectopic lesions, we performed immunohistochemistry for PCNA in endometriotic tissues at day 15, 30 and 60 post-surgeryand compared it to controls (Fig.4A ). In the control animals at diestrus stage, very few epithelial and stromalcells were positive for PCNA; but in the ectopic lesions, the numbers of PCNA positive cells appeared higher in both glandular epithelium and stroma at all the time points. Quantitatively, there was almost 5-10 fold increase in numbers of PCNA positive cells in epithelium of ectopic lesions as compared to controls at all the time points; this increase was statistically significant (P<0.001). Temporally, the number of PCNA positive cells in the epithelium increased significantly from day 15 to day 60 ( Fig.4B) .
As compared to controls, there was a significant (P<0.001) increase in PCNA positivestromal cells at all the time points. As compared to day 15, the number of PCNA positive cells was higher in stromal cells on day 30 and 60( Fig.4B ).
Aromatase gene expression is altered in ectopic endometrium
Abundant Cyp19a1 mRNA was detected in the ovary (used as positive controls) but not in the control endometrium indicating the specificity of our amplification. However, low abundance Cyp19a1 transcripts were detected in the endometriotic tissues at all time points. Quantitatively, in the ectopic lesions, Cyp19a1 transcripts were highest on tissues obtained at day 15, which declined as time progressed. As compared to day 15, the expression of Cyp19a1 was 1.5folds low on day 30and almost absent on day 60 ( Fig.5A ).
Kinetics of mRNA expression of steroid hormone receptors in ectopic endometrial lesion
To assess thechanges in expression of steroid hormone receptors, we performed quantitative real time PCR (qPCR) for steroid hormone receptor genes (Esr1, Esr2, Gperand Pgr) in diestrus stage ectopic endometrial tissues on day 15, 30 and 60 post-surgery. The eutopicendometriumin diestrus stage was used as control ( Fig.5 ).
Estrogen receptorgene1 (Esr1) and Estrogen receptor gene2 (Esr2)
As compared to controls, ectopic endometrial lesions had 10 foldhigher expression of Esr1 on day 15which decreased to 5 fold on day 30 as compared to controls. Further, at day 60, mean level of Esr1 increased to 3 fold as compared to controls. However, this increase was not statistically significant any time point (Fig.5B) . Expression of Esr2 was increased across all the time points in endometriotic tissues as compared to controls.There was almost 50-foldincrease inmean mRNA levels of Esr2at all three days ( Day 15, 30 & 60) . However,at any of the time point these changes were not statistically significant and there was a high variation across biological replicates (Fig.5C ). Although the mean levels ofEsr1 and Esr2 levels were higher as compared to control; the levels for both Esr1 and Esr2 were higher only in 30-40% animals while the levels were identical or lower than controls in 60-70% animals.Thus, it appears that the failure to achieve statistical significant results for both Esr1 and Esr2 isdue to wide variations across the biological replicates. G protein-coupled estrogen receptor gene (Gper) As compared to controls, Gper mRNA levels were lower in endometriotic lesionson day 15 and 30 which reached close to normal level on day 60. However, except at day 30, the differences were not statistically significant (Fig.5D ). Similar to Esr1 and Esr2 mRNA levels, there was variation in the levels of Gper across biological replicates. However, these variations were less dramatic as compared to Esr1 and Esr2in endometriotic tissues.
Progesterone receptor gene (Pgr)
The mean levels of Pgr mRNA were identical between endometrium of controls and endometriotic tissues on day 15. Pgr mRNA levels were almost 10 fold lower in the endometriotic tissue than controls on day 30 and day 60. Irrespective of these changes, the difference in the mRNA levels between endometriotic tissues and controlswere not statistically significant (Fig.5E ).
Altered spatio-temporal kinetic in ectopic endometrium
Immunohistochemistry was performed to study localization and abundance of ERα, ERβ, GPER1 and PR proteins in endometriotic tissues on day 15, 30 and 60 post-surgery at diestrus stage. Endometrial tissue in diestrus stage was used as control.
Estrogen receptor alpha (ERα)
In the endometrium of control animals, the expression of ERα was generally nuclear and appeared higher in epithelial cells as compared to stromal cells. As compared to controls, in endometriotic tissues, epithelial expression of ERα appears reduced on all days while stromal expression of ERα was maintained (Fig.6A) . Quantitative estimation revealed that as compared to controls, the ERα levels were marginally lower on day 15, 30 and 60; however, this reduction was not statistically significant (Fig.7A) . To test if ERα is differentially regulated in the epithelial versus stromal cells, quantifications were done separately in both the cell types. In the epithelial cells, as compared to controls, the expression of ERα in the endometriotic tissue was reduced at day 15 and was identical to controls at day 30 and 60. In the stromal cells, the expression of ERα was reduced at all time points as compared to control. However, this decrease was statistically significant (P<0.05) only at day 15 as compared to control (Fig.7A) .
Estrogen receptor beta (ERβ)
In the endometrium of control animals, ERβ was detected in the cytoplasm of the epithelial cells; the expression in stroma was negligible. In the endometriotic tissues, ERβ often appeared nuclear in both stromal and epithelial cells; the intensity of ERβ staining was also higher in ectopic endometrium as compared to controls (Fig.6B) . As compared to controls, the expression of ERβ was almost 2-5 fold higher in the endometriotic tissues on day 30 and 60. However, this increase was not statistically significant (Fig.7B) . In epithelial cells, the expression of ERβ was marginally lower than controls at all the time points. In the stromal cells, as compared to controls, levels of ERβ in ectopic endometrium were higher by 1.5-3 folds on all days (day 15, 30 & 60) . However, this increase was statistically significant (P<0.05) only at day 15 as compared to controls (Fig.7B) .
G protein-coupled estrogen receptor (GPER1)
In endometrium of control animals, GPER1 staining was strong in the epithelium and weak in the stroma. The expression was cytoplasmic and appeared higher on the apical membrane of epithelial cells. As compared to eutopic endometrium of control animals, the intensity of GPER1 appeared lower in the endometriotic tissues (Fig.6C) . Quantitatively, ~5 fold reduction in the levels of GPER1 in the endometriotic tissues as compared to controls on all days (15, 30& 60) . This reduction was statistically significant (P<0.05) at all the time points (Fig.7C ).As observed in Fig.7C , GPER1 protein was significantly (P<0.05) lower in both epithelial and stromal compartment of the endometriotic tissue as compared to control. In both cell types, the reduction of GPER1 was ~ 5-10 fold and statistically significant (P<0.05) on all three days. Progesterone receptor (PR) PR was detected in the nucleus of both epithelial and stromal cells of the eutopic endometrium. In the ectopic endometrium, the intensity of PR staining was low both in the epithelial and stromal cells, in most cases, the staining was cytoplasmic. As compared to controls, expression of PR was significantly (P<0.05) lower in the endometriotic tissues at all the time points. This reduction was almost 5-10 folds. In almost 50% of animals, there was extremely low PR expression in the endometriotic tissue as compared to controls (Fig.6D & 7D) . Levels of PR were also quantified separately in epithelial and stromal cells. As compared to controls, expression of PR was lower in epithelial cells of ectopic endometrium on day 15 and 30 which declined further on day 60. When compared to controls, this reduction was statistically significant (P<0.05) at all the time points. In case of stromal cells, the expression of PR was lower as compared to controls. Quantitatively, there was almost 5-10 fold reduction in the expression of PR. This reduction of PR in the stromal cells of ectopic endometrium was statistically significant (P<0.05) as compared to controls. The downregulation of PR was more dramatic in the stromal cells as compared to epithelial cells in endometriotic tissue.
Micro-heterogeneity in expression of steroid hormone receptors in ectopic endometrial lesion
From the above result, we observed that the expression of steroid hormone receptors although altered in the endometriotic tissues as compared to controls; at many instances the differences were not statistically significant and there was a high variability across biological replicates. (Fig.7) . During the quantification of immunostaining of steroid hormone receptors in ectopic lesions, we observed that intensity of staining was not uniform across the entire tissue section of lesion while uniform staining was observed in the endometrium of control animals (Fig.8) . Also, the expression of cytokeratin and vimentin was found to be uniform across all the sections from ectopic location with little variations between the animals. Thus, it is logical to assume that these changes are not due to technical differences in tissue processing (Fig.3) . Hence, we asked if the high biological variability observed in the endometriotic tissue is due to the intra-lesion variability.
To address this question, we quantified the intensity of immunostaining for the steroid hormone receptors in 10 random areas of 3 non-serial sections of endometriotic tissue from three biological replicates onday 60post-surgery andcompared the intensity values in each area. As observed in Fig.8 , in the controls, the expression of ERα, ERβ, GPER1 and PR were more or less uniform across the tissues and there was little inter sample variability. However, there was high variability in intensity of staining in different areas of same section of endometriotic tissue and this was observed across all biological replicates. For both ERα and ERβ, the expression in some areas of the endometriotic tissue sectionswas more than the controls; in other areas of the same sections the expression was lower than controls (Fig8A & 8B) . Similarly, in case of GPER1 &PR, there was high heterogeneity in the intensity of the staining across the sections obtained from ectopic tissue; the expression was; however, always lower than control animals ( Fig.8C & 8D) .
Tissue autonomous regulation of steroid hormone receptors in ectopic endometrial lesion
Clinically endometriosis is characterized by the presence of several lesions in the pelvic peritoneum. We asked if the changes in the expression of steroid hormone receptors observed in endometriotic tissue is lesion independent or the regulation is identical. To test this, two pieces of endometrial tissue were ligated separately onto intestinal mesentery and tissues were excised after 60 days. Both the tissues were independently processed either for qPCR or immunohistochemistry. All the comparisons were made only in the paired tissue of each animal at both gene and protein level. Estrogen receptor genes (Esr1,Esr2and Gper) In 6 out of 7 animals, the expression of Esr1 was discordant between the two lesions obtained from the same animal; in one animal theexpression of Esr1 between two lesions was identical (Fig.9A) . In most of the animals, difference in the expression of Esr1 between two lesions was in the range of 5-10 folds. The expression of Esr2was discordant between two lesions in all the seven animals; in 3/7 animals, there was more than 10 fold differences (Fig.9B) . Similarly, the expression of Gper was discordant between the two lesions of same animal. In6/7 animals, the difference in the level of Gper between two lesions of same animal was more than 5 fold while in one animal; the level of Gper was identical between two lesions (Fig.9C) .
Progesterone receptor gene(Pgr)
In 5/7 animals, the expression of Pgr was discordant between two lesions from the same animal; in two animals the levels of Pgr mRNA were identical. Amongst the 5 animals that had discordant levels of Pgr between the two lesions, in 3 animals the difference was almost10 fold while in other two animals, the difference was more than100 fold (Fig.9D ). Next, we tested if the discordancy in the mRNA levels of steroid hormone receptors between the two lesions also reflected at the protein levels. We compared intensity of ERα, ERβ, GPER1 and PR proteins in two immunostained endometriotic tissue sections of same animal. Like the mRNA, protein levels of steroid hormone receptors were also found to be discordant between the two lesions obtained from the same animal. In general, variation was in the range of 1.5-3 folds between the two ectopic endometrial lesions of same animal (Fig.10) .
DISCUSSION:
In the present study, we demonstrate that surgical implantation of the mouse uterine fragments at ectopic location (intestinal mesentery) lead to development of ectopic endometrial lesions. These ectopic lesions grow and progressively acquires histomorphological characteristics similar to human endometriosis. We further show that there is dysregulation in the expression of steroid hormone receptors (ERα, ERβ, GPER1 and PR) in different cell types of endometriotic tissue in a time dependent manner. This dysregulation is not uniform and there is extensive micro heterogeneity in the expression of steroid hormone receptors which seem to be regulated by tissue autonomously. However, in present study, most of the lesions aretranslucent and pale even in the early stages. In less than 10% of the animals,there is some blood in the lesions.
We next characterized histological ontogeny of the surgically induced endometriotic lesions. In the present study, most of the lesions collected had well-differentiated histomorphology where the epithelium was well defined and often appeared multilayered in some areas indicative of high proliferative activity. However, in 40% of samples, there was a mixed phenotype where in some areas of the glands, the epithelial layer appeared flattened. Mixed phenotypes were generally observed in the lesions obtained on day 45 It has been shown that the ectopic endometrium gains an ability to locally produce estrogen by expression of aromatase gene. Both, transcripts and protein for aromatase reported in ectopic lesions of women with endometriosis, production of aromatase at ectopic location was also observed in baboons with induced endometriosis (Qi et al. 2017, Attar et al. 2009 ). In the present study, low but specific transcripts of Cyp19a1 weredetected in endometriosis as early as day 15 suggesting an increased local synthesis of estrogen. Corroborating this data, a previous study has reported expression of aromatase in 66% of endometrial lesions 4 weeks post transplantation and the growth of the lesion could be suppressed by treatment with aromatase inhibitors (Bilotas et al.  2010) . However, it must be noted that herein, we observed a reduction in the abundance of Cyp19a1 transcripts indicating that local estrogen synthesis may be a feature of early endometriosis, the tissue might lose the ability to produce estrogen with time. This is in contrast with the observations in baboons where aromatase transcripts was detected in the endometriotic lesions only after 10 months of induction which respond to treatment with aromatase inhibitors (Langoi et al. 2013, Fazleabas et al. 2003) . Estrogen acts via its receptors mainly ERα and ERβ. In cyclic endometrium, ERβ is constitutively expressed while the level of ERα is altered with the phase of the endometrial cycle in response to estrogen (Koehler et al. 2005) . Functionally, ERα is required for endometrial cell proliferation while ERβ is necessary for regulation of immune responses (Hen et al. 2015) .In the context of endometriosis, both ERα and ERβ have been thought to be essential for growth and development of endometriosis (Qian et al. 2016) . In the context of endometriosis, there is a single report demonstrating that the expression for GPER1 is increased in ectopic endometrium of women with endometriosis (Plante et al. 2012) .To understand if there are any changes in expression of ERs and GPER1 during the course of disease progression in the mouse model of endometriosis, we analyzed their expression profiles in the ectopic endometrium on day 15, 30 and 60 post-surgery. The results reveal that mRNA levels of Esr1, Esr2andGper are altered in the ectopic endometrium during the course of lesion development, however there was high inter-animal variability. We suspected that such differences might arise due altered expression of these molecules in a cell type specific manner and these may not be reflected in whole tissue lysate. Indeed, immunostaining of the tissue sections revealed that the expression of ERα, ERβ and GPER1were reduced in the epithelial cells of endometriotic tissue with more dramatic reduction in levels of GPER1 as compared to ERα and ERβ. Interestingly, in the stromal cells, the expression of ERα and GPER1 was reduced as compared to controls at all the time points, while that of ERβ progressively increased. These results imply that there are cell type specific changesin expression of estrogen receptors in ectopic endometrium and both canonical and non-canonical actions of estrogen are affected in endometriosis. .
In the cycling endometrium, progesterone acts via its receptors to induce differentiation required to attain receptivity and promote implantation (Wetendorf et al. 2014 ). In women with endometriosis, although serum levels of progesterone are similar to those of women without the disease, it is well established that endometriotic lesions (ectopic endometrium) do not respond appropriately to progesterone. This is thought to be because oflower levels of PR in endometrium of women with endometriosis (McKinnon et al. 2018, Patel et al. 2017) . Corroborating the human data, in the present study, the expression of PR was also reduced in both epithelium and stroma of the endometriotic tissue as compared to endometrium of control animals. Together these observations imply that the canonical andnon-classical ER & PR signaling are hampered in endometriotic tissue. In the present study, we observed that irrespective of the receptors there was high inter-sample variability. In a recent study, similar high inter-subject and intra-subject variation in the PR levels was reported in human endometriotic lesions (Flores et al. 2018) .In addition to high intraanimal variability, quantitative analysis of different regions of same section reveal that the expression of ERα, ERβ, GPER1 and PR were higher in the certain areas of the sections while almost absent in other area of same section. We termed these variations as micro-heterogeneity and quantified it across the biological replicates. The results revealed that the expression of all these proteins varies as much as 100 fold between adjacent areas of the same section and this was also observed in all the endometriotic lesions examined. This micro-heterogeneity was not due to technical errors during tissue processing as expression of other proteins (vimentin and cytokeratin) was homogenous in the same sections with minimal biological variability across the samples. We next addressed whether this micro-heterogeneity is driven by systemic clue or it is tissue autonomous. To answer this question, we surgically implanted two pieces of endometrial tissue adjacently in the same animal, harvested 60 days later and processed them independently. The results reveal that there was no concordance in the levels of steroid hormone receptors between the two lesions isolated from the same animal. This was also reflected at the protein levels where one lesion has higher expression than normal while others have lower expression than normal. This was true for all ERα, ERβ, GPER1 and PR implying that micro-heterogeneity observed in the endometriosis is tissue autonomous and is not systemically driven. At present, it is difficult to speculate what would be the reason for such micro-heterogeneity. In endometriosis, altered expression of ER and PR are thought to be due to differential levels of the DNA methylation of their cognate genes in the genome (Xue et al. 2007, Wu et al. 2006).We suspect that such methylation changes may not have uniformly occurred throughout the tissue and this may contribute to such differential expression of these receptors. From the results of the present study, we suspect that the discordant results obtained in different studies on expression of steroid hormone receptors could arise due to site and time of tissue sampling. Thus, one needs to be very cautious while interpreting the data from such studies and concept of micro-heterogeneity must be borne in mind while analyzing the data on endometriotic tissue. In the context of steroid hormone receptors, our results demonstrate that there is high inter and intra lesion variability which could also alter with time. This implies that the sensitivity to exogenous steroid hormones may not be uniform. Several systematic reviews including the Cochran data bases have observed that despite high quality study design, there is inconsistency in the outcomes of steroidal therapies between different studies (Bozdag et al. 2015) . It is possible thatthe inconsistency across studies in response to hormone therapies is not due to methodological issues but is inherent to endometriosis. It is plausible that temporal and spatial difference in the expression of steroid hormone receptors coupled with micro-heterogeneity may alter the effectiveness of steroid hormone analogues resulting in variable outcomes and often failure of therapy.
In summary, the results of the present study have shown that it is possible to partially mimic the stage I-IV of well differentiated endometriosis in the mouse model. However, our results show that there are some differences in the evolution of endometriosis in human subjects and in this system. Furthermore, herein, we demonstrate that there is extensive heterogeneity in the expression of classical and non-classical steroid hormone receptors in the endometriotic tissues which cautious us regarding the therapeutic use of steroid hormone modulators in women with endometriosis. We believe that characterizing the mouse model of endometriosis would be animmense developing rationale for diagnosis and aid in management strategy for this common but as of yet untreatable disorder.
MATERIAL AND METHODS

Animal Ethics
This study was approved by the Institutional Animal Ethics Committee (IAEC) of the National Institute for Research in Reproductive (NIRRH) and committee for Biosafety. Animals 3-4 month old regularly cyclingC57BL/6 strain mice were used for study. Mice housed in environmentally controlled cages, with 12 h day night cycles.
Endometriosis induction
Endometriosis was surgically induced in the mice as described previously (Pelch et al. 2012) . Briefly, mice in diestrus and estrus stage were anesthetized by ketamine and xylazine.Small incision was given on skin and muscleto expose the uterine horns. The left uterine horn was excised, opened medially and cut into 3 small fragments. Onefragment was sutured with the intestinal mesentery; muscles and skin were sutured back andthe animal was revived in a 37°C warm chamber and put back to the cage. In some experiments, two fragments were sutured individually at a distance on the intestinal mesentery.
Experimental Tissue collection
Animals were sacrificed on day 5, 10, 15, 30, 45 and 60 post-surgery. The tissue attached to intestinal mesentery was excised and stored in Trizol reagent for RNA extraction or fixedin 4% PFA for paraffin embedding and sectioning. In some cases, more than one lesion was sutured in the same animal; both the lesions were excised and processed individually.For controls, uterus from 3-4 month old female mice were alsocollected in Trizol reagent for RNA extraction and in 4% PFA for paraffin embedding and sectioning.
RNA Extraction &cDNA Synthesis
Total RNA was extracted using Trizol reagent (Invitrogen), treated with DNase (GE Healthcare, Hongkong, China), and reverse transcribed by Clonetech cDNA synthesis kit as described previously (Godbole et al. 2007 ).
Quantitative Real Time PCR
Specific primers were designed to check the expression of Esr1, Esr2, Cyp19a1, Gper and Pgr. The data was normalized to the level of 18srRNA. The primer sequences for the above genes are given in Table1.Real time PCR was done in triplicates as detailed previously (Godbole et al.
2007, Lahari et al. 2018).
All amplifications were done using theCycler Real Time PCR System (Bio-Rad) andSybr Green Chemistry (Biorad). For each primer pair, reaction efficiency was estimated by the amplification of serial dilution of mouse uterus cDNA pool over 5 fold range. The amplification condition for each primer were: initial denaturation at 98⁰C for 2 minutes followed by 40 cycles of denaturation at 98⁰C for 30s, primer annealing at their respective optimized T a and extension at 72⁰C for 45s, melt curve 75⁰C to 95⁰C. The fluorescence emitted at each cycle was collected for the entire period of 30s during the extension step of each cycle. The homogeneity of the PCR amplicons was verified by the melt curve method. All PCR was carried out in triplicates. Mean Cq value generated in each experiment using the iCycler software (Bio-Rad) were used to obtain the standard curve,).The relative expression ratios were calculated using Livak method 
Hematoxylin & Eosin Staining
Five micrometers thick paraffin sections of 4% PFA fixed tissueswere cut and mounted on poly-L-lysine coated slides. Sections were deparaffinised in xylene, hydrated in descending grades of alcohol for 5 minutes. After that endometriotic tissue sections were stained with hematoxylin stain (Himedia)followed by eosin (Himedia) and mounted. Slides were viewed under bright field microscope (Olympus)and representative areas were photographed.
Immunohistochemistry
Immunohistochemistry was performed as described previously (Godbole et al. 2007, Laheri et al. 2017).Five micrometers thick sections were deparaffinised in xylene, hydrated in descending grades of alcohol. Antigens were retrieved by Tris-EDTA Buffer (pH-9), blocking was done in 5% BSA and the sections were probed overnight with primary antibody. Negative controls were incubated with PBS instead of primary antibody. Next day, slides were washed three times with PBS for 10 minutes and incubated with biotinylated secondary antibody followed by incubation in streptavidin-HRP (ABC Santa Cruz Biotechnology) for 30 minutes. Detection was done using hydrogen peroxidase substrate and Diaminobenzidine (Sigma Aldrich) as chromogen. All sections were briefly counterstained with hematoxylin and mounted. Slides were viewed underbright Field microscope(Olympus) and representative areas were photographed.
Immunostaining Score
Immunostaining was quantified in terms of intensity numbers by "Fiji" version of ImageJ. To quantify immunostaining for individual proteins in endometrium, we selected three different images showing different area of same lesion and calculated the intensity numbers. For individual cell types, stromal and epithelial cells, we selected randomly 10 different areas of 2000m 2 in stroma and epithelia and calculated intensity numbers. To quantify microhetergeneity, we selected 10 random areas of 2000m 2 in 3 non-serial sections of 3 biological replicates and quantified intensity number same as done for stromal and epithelial cells. This intensity number was further converted into optical density (OD) with the following formula in MS Excel sheet. Optical Density (OD) = log (max intensity/Mean intensity), where max intensity = 255 for 8-bit images.
Statistical Analysis
All experimental quantitative data of various genes and proteins was calculated in terms of Mean and Standard deviation, and statistical analysis was done using GraphPad Prism, version 5, either by one-way ANOVA using Tukey's all column comparison test or Student's unpaired t test. P< 0.05 was accepted as statistically significant.
